2026
MILESTONE / ANNUAL PROGRESS
Expanding Footprint, Driving Innovation
- Facility Construction: Designed by internationally renowned architect Kris Yao, groundbreaking officially commenced for the new Zhunan plant in Miaoli.
- Acquisition Completion: Acquired 100% equity of Leeman Biotechnology Co., Ltd., fully integrating northern and southern facility resources.
- Clinical Trials: 18F-FBPA officially approved by the MOHW for clinical trials.
- R&D Advancement: Development of AV-133 and 161Tb PSMA I&T radiolabeled therapeutic products is progressing steadily.
2025
VISION / OUTLOOK
Entering New Technological Frontiers
- Procured the production cyclotron for the Miaoli Zhunan plant.
- Acquired an 80% stake in Leeman Biotechnology Co., Ltd.
- Signed a technical cooperation agreement with South Korea's DuChembio.
- Board of Directors approved self-construction of the Miaoli plant facilities.
2024
GROWTH / STRATEGIC DEPLOYMENT
Expansion & Capital Deepening
- 2024: Completed public offering and listed on the Emerging Stock Board (Stock Code: 7762).
- 2024: Signed an 18F-FBPA CDMO contract with Taiwan JMC (7799).
- 2024: Implemented plant-office separation by establishing the Huaku office, enhancing administrative and R&D support capabilities.
- 2023: Signed the land purchase agreement for the new Miaoli Zhunan plant, initiating site expansion.
2022
R&D / PRECISION MEDICINE
Core Drug Licenses Secured
- 2022: Obtained drug license for 18F-NaF (bone metastasis imaging).
- 2021: Obtained Atomic Energy Council (AEC) approval to increase cyclotron production capacity.
- 2018: Obtained drug license for Neuraceq (Alzheimer's disease imaging).
2017
EXPANSION / TECH TRANSFER
Capacity & Licensing
- 2017: Obtained the Cyclotron Operation License from the Atomic Energy Council.
- 2017: Obtained the drug license for 131I sodium iodide solution (thyroid cancer therapy).
- 2016: Acquired original technology transfer from LMI for Neuraceq production.
- 2015: Obtained MOHW drug license for 18F-FDG (cancer imaging).
2014
GLORY / MILESTONE MOMENT
Asia's First Certification
🏆 Awarded MOHW PIC/S GMP Certification
Became the first private radiopharmaceutical sterile preparation manufacturer in Asia to pass the certification.
2011
FOUNDATION / ESTABLISHMENT
Company Founding
- 2013: Submitted application for PIC/S GMP certification.
- 2012: Obtained pharmaceutical manufacturing license.
- 2011: Officially approved and established.